• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Viruses . Differential Viral-Host Immune Interactions Associated with Oseltamivir-Resistant H275Y and Wild-Type H1N1 A(pdm09) Influenza Virus Pathog

tetano

Editor, Senior Moderator
Viruses


. 2020 Jul 24;12(8):E794.
doi: 10.3390/v12080794.
Differential Viral-Host Immune Interactions Associated with Oseltamivir-Resistant H275Y and Wild-Type H1N1 A(pdm09) Influenza Virus Pathogenicity


Beatriz Vida?a[SUP] 1 2 [/SUP], Pamela Mart?nez-Orellana[SUP] 2 3 [/SUP], Jaime M Martorell[SUP] 4 [/SUP], Massimiliano Baratelli[SUP] 2 5 [/SUP], Jorge Mart?nez[SUP] 2 6 [/SUP], Lourdes Migura-Garcia[SUP] 2 [/SUP], Lorena C?rdoba[SUP] 2 [/SUP], M?nica P?rez[SUP] 2 [/SUP], Inmaculada Casas[SUP] 7 [/SUP], Francisco Pozo[SUP] 7 [/SUP], Lorenzo Fraile[SUP] 8 [/SUP], Nat?lia Maj?[SUP] 2 6 [/SUP], Mar?a Montoya[SUP] 2 9 [/SUP]



Affiliations
Free article

Abstract

Oseltamivir is a common therapy against influenza A virus (IAV) infections. The acquisition of oseltamivir resistance (OR) mutations, such as H275Y, hampers viral fitness. However, OR H1N1 viruses have demonstrated the ability to spread throughout different populations. The objective of this work was to compare the fitness of two strains of OR (R6 and R7) containing the H275Y mutation, and a wild-type (F) pandemic influenza A (H1N1) 2009 (pdm09) virus both in vitro and in vivo in mice and to select one OR strain for a comparison with F in ferrets. R6 showed faster replication and pathogenicity than R7 in vitro and in mice. Subsequently, R6 was selected for the fitness comparison with the F strain in ferrets. Ferrets infected with the F virus showed more severe clinical signs, histopathological lung lesions, and viral quantification when compared to OR R6-infected animals. More importantly, differential viral kinetics correlated with differential pro-inflammatory host immune responses in the lungs of infected ferrets, where OR-infected animals developed a protective higher expression of type I IFN and Retinoid acid Inducible Gene I (RIG-I) genes early after infection, resulting in the development of milder disease. These results suggest the presence of early specific viral-host immune interactions relevant in the development of influenza-associated lung pathology.

Keywords: immunopathology; influenza; oseltamivir; pH1N1; pneumonia; resistance.
 
Back
Top Bottom